- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Pediatrix Medical Group, Inc.(MD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MD
11/13/2026: MD (5-star) is a STRONG-BUY. BUY for 22 days. Simulated Profits (12.75%). Updated daily EoD!
Mednax Inc, operating as Pediatrix Medical Group, is a specialized healthcare services company that provides essential neonatal, maternal-fetal, and pediatric physician staffing to hospitals across the United States. Following a strategic shift to divest non-core assets, the company is now focused on its historical expertise in high-acuity care. Its primary growth opportunity lies in leveraging its deep hospital integration to expand clinical services and digital healthcare delivery. However, investors must monitor risks related to rising labor costs, hospital in-sourcing trends, and potential volatility in healthcare reimbursement policies. This stock may suit investors seeking exposure to specialized clinical services while remaining aware of the cyclical and regulatory challenges inherent in healthcare.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is limited by the mature nature of hospital-based staffing and regulatory constraints. |
| Momentum investor | Weak fit | The stock lacks consistent breakout momentum and is often range-bound by healthcare policy news. |
| Value investor | Strong fit | The stock may offer value for those betting on a turnaround in profitability post-restructuring. |
| Dividend investor | Weak fit | The company does not prioritize regular dividend payouts to shareholders. |
| Low-risk investor | Weak fit | Healthcare regulatory and labor-related volatility make this a higher-risk investment. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is susceptible to swings based on healthcare policy changes and quarterly results. |
| Valuation risk | Medium | Valuation depends heavily on the successful execution of the new, focused business strategy. |
| Competition risk (hospital in-sourcing) | High | Hospitals increasingly moving to direct employment of physicians threatens external staffing models. |
| Business quality | Medium | While the clinical reputation is strong, the financial margin profile is sensitive to labor costs. |
| Dividend income | Low / none | Shareholder returns are not centered on recurring dividend income. |
| Execution risk | Medium / high | Successfully integrating and scaling pediatric subspecialties across multiple states is operationally complex. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.45B USD | Price to earnings Ratio 17.1 | 1Y Target Price 30.08 |
Price to earnings Ratio 17.1 | 1Y Target Price 30.08 | ||
Volume (30-day avg) 717.8K shares | Beta 0.61 | 52 Weeks Range 17.23 - 33.74 | Updated Date 11/14/2026 |
52 Weeks Range 17.23 - 33.74 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.83 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 87.43% | Avg. Invested days 45 | Today’s Advisory Strong Buy |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Physician Services | Clinical staffing for NICUs, maternal-fetal, and pediatric units. | The company collects fees from hospitals and insurance providers for the specialized medical care its physicians provide. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-10-29 | When Before Market | Estimate 0.59 | Actual 0.67 |
Profitability
Profit Margin 7.66% | Operating Margin (TTM) 12.15% |
Management Effectiveness
Return on Assets (TTM) 6.86% | Return on Equity (TTM) 17.25% |
Valuation
Trailing PE 17.1 | Forward PE 9.29 | Enterprise Value 2.64B | Price to Sales(TTM) 1.25 |
Enterprise Value 2.64B | Price to Sales(TTM) 1.25 | ||
Enterprise Value to Revenue 1.35 | Enterprise Value to EBITDA 10.13 | Shares Outstanding 78.12M | Shares Floating 74.86M |
Shares Outstanding 78.12M | Shares Floating 74.86M | ||
Percent Insiders 2.11 | Percent Institutions 110.3 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

